Inventor
BLOKHIN ANDREI V
US25 patents
⚠️ This page may combine multiple inventors who share the name “BLOKHIN ANDREI V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARROWHEAD MADISON INC
6 patentsUS9976141B2May 22, 2018
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD MADISON INC5 citations82
US9107957B2Aug 18, 2015
Peptide-based in vivo siRNA delivery system
ARROWHEAD MADISON INC5 citations81
US9487556B2Nov 8, 2016
Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
ARROWHEAD MADISON INC6 citations80
US10059681B2Aug 28, 2018
Disubstituted maleic anhydrides with altered kinetics of ring closure
ARROWHEAD MADISON INC0 citations51
US10005815B2Jun 26, 2018
Biologically cleavable tetrapeptide linking agents
ARROWHEAD MADISON INC0 citations51
US9803201B2Oct 31, 2017
Disulfide-containing alkyne linking agents
ARROWHEAD MADISON INC1 citations51
ARROWHEAD PHARMACEUTICALS INC
5 patentsUS10246709B2Apr 2, 2019
Targeting ligands for therapeutic compounds
ARROWHEAD PHARMACEUTICALS INC10 citations83
US10927373B2Feb 23, 2021
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC2 citations71
US12116573B2Oct 15, 2024
Targeting ligands for therapeutic compounds
ARROWHEAD PHARMACEUTICALS INC0 citations62
US11840688B2Dec 12, 2023
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC0 citations61
US10047361B2Aug 14, 2018
Disulfide-containing alkyne linking agents
ARROWHEAD PHARMACEUTICALS INC0 citations51
CELLGATE INC
4 patentsUS6982351B2Jan 3, 2006
Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
CELLGATE INC38 citations94
US7186825B2Mar 6, 2007
Conformationally restricted polyamine analogs as disease therapies
CELLGATE INC15 citations91
US7253207B2Aug 7, 2007
Quinones as disease therapies
CELLGATE INC11 citations82
US7026347B2Apr 11, 2006
Porphyrin-polyamine conjugates for cancer therapy
CELLGATE INC14 citations81
ROZEMA DAVID B
3 patentsUS8501930B2Aug 6, 2013
Peptide-based in vivo siRNA delivery system
ROZEMA DAVID B180 citations98
US8426554B2Apr 23, 2013
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
ROZEMA DAVID B47 citations97
US8802773B2Aug 12, 2014
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
ROZEMA DAVID B12 citations92